ID
25764
Description
Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome AE Section
Keywords
Versions (2)
- 9/18/17 9/18/17 -
- 9/18/17 9/18/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 18, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
AE Section GSK Ropinirole Restless Legs Syndrome 101468
AE Section GSK Ropinirole Restless Legs Syndrome 101468
- StudyEvent: ODM
Description
Form D
Alias
- UMLS CUI-1
- C0011065
Description
Complete Serious Adverse Event Form.
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Date of Death
Data type
date
Measurement units
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C1148348
Description
Autopsy
Data type
boolean
Alias
- UMLS CUI [1]
- C0004398
Description
Autopsy Specification
Data type
text
Alias
- UMLS CUI [1]
- C2348235
Description
Investigator's Name
Data type
text
Alias
- UMLS CUI [1]
- C2826892
Description
Date of Report
Data type
text
Measurement units
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C1302584
Similar models
AE Section GSK Ropinirole Restless Legs Syndrome 101468
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
No comments